RTW Investments’s Apollo Endosurgery, Inc. APEN Stock Holding History

RTW Investments’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-258,064	Closed	-$942K	–	108
2022 Q2	$942K	Hold	258,064	–	–	0.02%	100
2022 Q1	$1.56M	Hold	258,064	–	–	0.03%	92
2021 Q4	$2.17M	Buy	+258,064	New	+$2.25M	0.03%	107
2015 Q2	–	Sell	-779	Closed	-$148K	–	41
2015 Q1	$148K	Hold	779	–	–	0.07%	21
2014 Q4	$169K	Buy	+779	New	+$174K	0.06%	21

Other funds holding APEN

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

RTW Investments's APEN Position: Q3 2022 in Review

RTW Investments sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2022, closing a stake of 258,064 shares — an estimated $942K sold.

RTW Investments first reported a position in APEN in Q4 2014 and held it in 5 quarters. The position peaked at $2.17M in Q4 2021. 53 funds tracked by Wall St. Rank hold APEN as of Q3 2022.

RTW Investments reported no remaining Apollo Endosurgery, Inc. position as of Q3 2022 after selling out during the quarter.
RTW Investments sold 258,064 Apollo Endosurgery, Inc. shares in Q3 2022, an estimated $942K.
RTW Investments first reported a position in Apollo Endosurgery, Inc. in Q4 2014 and held it in 5 quarters.
RTW Investments's Apollo Endosurgery, Inc. position peaked at $2.17M in Q4 2021.
53 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2022.

Based on RTW Investments's 13F filing for Q3 2022, filed 14 Nov 2022.